Insulin Inhalation
Links shared publicly online about this topic
A Step Back For Mannkind: Delay For Insulin Inhaler // Pharmalot
pharmalot.com — “A Step Back For Mannkind: Delay For Insulin Inhaler // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on January 11, 2010 at 1:22 pm By:
Best headline ever (but not so good for Mannkind): A Step Back For Mannkind: Insulin Inhaler Is Delayed. http://is.gd/646JI (Pharmalot)
For diabetics, an insulin inhaler that does away with needles - SmartPlanet
smartplanet.com — “A new handheld device may let diabetics inhale a dose of insulin instead of using a needle to control blood sugar levels. Valencia, Calif.-based drug” View full resource at smartplanet.com
Most Recently Shared on October 14, 2009 at 5:59 pm By:
For diabetics, an insulin inhaler that does away with needles - http://tinyurl.com/ylyogbu
The Bull Case For MannKind’s Insulin Inhaler - Robert Langreth - Treatments - Forbes
blogs.forbes.com — “I wrote a blog the other day that MannKind bulls hated. It detailed the bear case against Mannkind from analyst Avik Roy, who thinks the FDA's new four week delay in its decision on whether to approve the insulin inhaler is a sign that it will be rejected. Here's the [...]” View full resource at blogs.forbes.com
Most Recently Shared on December 30, 2010 at 5:11 pm By:
Drugs and Devices OW OW Health
The Bull Case For MannKind's Insulin Inhaler: I wrote a blog the other day that MannKind bulls hated. It d... http://bit.ly/hcdmZT #drug
Symposier - A New Type of Inhaled Insulin
symposier.com — “Uploaded and shared in Youtube by: ElsGlobalMedicalNews --" In a comparison of premeal inhaled Technosphere insulin plus glargine with twice-daily 70/30 insulin, the inhaled insulin lowered glucose with less hypoglycemia and weight gain, Dr. Daniel L. Lorber reports.” View full resource at symposier.com
Most Recently Shared on November 26, 2010 at 8:11 pm By:
Symposier Endocrino Health Site
A New Type of Inhaled Insulin, Lower Gluvoce but with less hypoglicemia than injected type. http://bit.ly/g9AW9r
Inhaled insulin: overview of a novel route of insulin administration
dovepress.com — “Inhaled insulin: overview of a novel route of insulin administration lucy d mastrandreadepartment of pediatrics, school of medicine and biochemical sciences, university at buffalo, buffalo, ny, usaabstract: diabetes is a chronic disease characterized by inadequate insulin secretion with resulting hyperglycemia. diabetes complications include both microvascular and macrovascular disease, both of which are affected by optimal diabetes control. many individuals with diabetes rely on subcutaneous in” View full resource at dovepress.com
Most Recently Shared on January 19, 2010 at 6:40 pm By:
Inhaled insulin: overview of a novel route of insulin administration - http://tinyurl.com/ykydkhm
Pulse - Inhaled insulin 'as good as standard therapy'
pulsetoday.co.uk — “Pulse - Inhaled insulin 'as good as standard therapy'” View full resource at pulsetoday.co.uk
Most Recently Shared on June 30, 2010 at 4:04 pm By:
PulseToday Health News and Medical Publisher
Inhaled insulin 'as good as standard therapy': A new inhaled insulin drug has shown promising results in patients ... http://bit.ly/bJFe1x
Inhaled Insulin May Help Treat Diabetes
crosspollinate.org — “Inhaled Insulin May Help Treat Diabetes” View full resource at crosspollinate.org
Most Recently Shared on June 28, 2010 at 5:38 pm By:
healthy_food Healthy Eating Advisor
Inhaled Insulin May Help Treat Diabetes #food http://bit.ly/aqFct1
Inhaled insulin appears to be on the rebound - - Drug Topics
drugtopics.modernmedicine.com — “Inhaled insulin may be making a comeback. That's the hope at MannKind, a California-based biopharmaceutical company developing a rapid-acting inhaled insulin known as Afrezza (insulin human rDNA origin).” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on July 9, 2010 at 10:40 am By:
Drugs and Devices OW OW Health
Inhaled insulin appears to be on the rebound: Inhaled insulin may be making a comeback. That's the hope at MannKin... http://bit.ly/bKJ5A2
FDA requests more data on inhaled insulin
endocrinetoday.com — “The FDA issued a complete response letter to MannKind Corporation requesting additional clinical trials to yield more information before approvi” View full resource at endocrinetoday.com
Most Recently Shared on January 20, 2011 at 4:16 pm By:
#FDA requests more data on inhaled #insulin http://bit.ly/frwSGG
Inhaled Insulin :: Diabetes Self-Management
diabetesselfmanagement.com — “A new inhalable powder awaits FDA approval — will it fare better than the last one?” View full resource at diabetesselfmanagement.com
Most Recently Shared on April 7, 2010 at 8:29 pm By:
Diabetes Self-Mgmt Health Site
#diabetes A new inhalable powder awaits FDA approval — will it fare better than the last one? http://bit.ly/atNo3Y
Mealtime Ultra-Rapid Acting Insulin For Inhalation Rather Than Injection
medicalnewstoday.com — “Scientists have described a new ultra-rapid acting mealtime insulin (AFREZZA™) that is orally inhaled for absorption via the lung. Because the insulin is absorbed so rapidly, AFREZZA's profi” View full resource at medicalnewstoday.com
Most Recently Shared on March 24, 2010 at 4:10 pm By:
MNT Drug Approvals Health News
Mealtime Ultra-Rapid Acting Insulin For Inhalation Rather Than Injection http://mnt.to/3znx #regulatory
Is Inhaled Insulin Delivery Still A Possibility? Why Has It Been A Commercial Failure?
medicalnewstoday.com — “The commercial failure of Exubera® (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug d” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2009 at 4:42 pm By:
Is Inhaled Insulin Delivery Still A Possibility? Why Has It Been A Commercial Failure?: The commercial failure o.. http://bit.ly/z5aaH
MannKind's inhaled insulin verdict delayed | Reuters
reuters.com — “BOSTON (Reuters) - MannKind Corp said U.S. regulators need an additional four weeks to complete their review of its experimental diabetes treatment, lifting the hopes of some investors who” View full resource at reuters.com
Most Recently Shared on December 28, 2010 at 5:15 pm By:
Lisa Richwine Health Communicator
MannKind's inhaled insulin verdict delayed http://tinyurl.com/232vv7b
FDA seeks more data on MannKind's inhaled insulin | Reuters
reuters.com — “BOSTON (Reuters) - U.S. regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on Monday” View full resource at reuters.com
Most Recently Shared on March 16, 2010 at 4:30 am By:
Hisham Rana, MD Doctor and Physician
News: FDA seeks more data on MannKind's inhaled insulin http://bit.ly/9kiGXu - #diabetes #health
UPDATE 3-MannKind's inhaled insulin verdict delayed | Reuters
reuters.com — “* Says FDA will not be able to complete review by Dec. 29 * Says FDA requires about 4 more weeks to complete review * Shares rise as much as 11.5 percent (Adds analyst comment, updates share price)” View full resource at reuters.com
Most Recently Shared on December 29, 2010 at 2:55 pm By:
Susan Heavey Health Communicator
Looks like another 4 wks until #FDA rules on $MNKD inhaled insulin: http://link.reuters.com/vyv93r #diabetes
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
FierceBiotech
FierceBiotech's 140, written by Managing Editor Maureen Martino. Join the largest and most active biotech news readership in the world at FierceBiotech.com.
-
SmartPlanet
Insight and ideas that impact your world. Cities. Design. Energy. Green. Innovation. Health. Science. Tech. Sustainability. Transportation. (From CBS.)
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
